Penumbra Inc. is a global healthcare company focused on innovative medical devices for the treatment of vascular and neurovascular conditions. The company's mission is to improve patient outcomes through the development of cutting-edge technologies that enhance the precision and effectiveness of minimally invasive procedures. Penumbra Inc. employs a strategy centered on research and development, aiming to expand its product portfolio and market reach while collaborating with healthcare professionals to address unmet clinical needs. Through its commitment to innovation and quality, Penumbra Inc. strives to transform patient care in the fields of interventional medicine.

PENUMBRA INC

Penumbra (PEN) is currently positioned strongly in the market, holding a Zacks Rank of #1 (Strong Buy) and is expected to achieve a notable growth rate of 37.5% for 2025. The company has demonstrated robust performance, having outperformed earnings estimates in three of the last four quarters with an average...

Penumbra (PEN) Positioned for Growth with Strong Earnings Track Record and Anticipated 37.5% Growth Rate for 2025

Penumbra (PEN) is on a remarkable trajectory, boasting a Zacks Rank of #1 and an anticipated growth rate of 37.5% for 2025. With a history of exceeding earnings estimates, can this momentum continue as the company prepares to unveil its fourth-quarter results?